Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial

Published:2021-11-19 Issue:3 Volume:30 Page:2569-2580
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Malta Cássia Emanuella Nóbrega^ORCID,Carlos Anna Clara Aragão Matos,de Alencar Manuele Carine Maciel,Alves e Silva Eveline Fernandes,Nogueira Victor Bruno Caitano,Alves Ana Paula Negreiros Nunes,Chaves Fábio Figueiredo,de Moura José Fernando Bastos,de Barros Silva Paulo Goberlânio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-021-06642-7.pdf

Reference45 articles.

1. Gadisa DA, Assefa M, Wang SH, Yimer G (2020) Toxicity profile of doxorubicin-cyclophosphamide and doxorubicin-cyclophosphamide followed by paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: a prospective cohort study. J Oncol Pharm Pract 26(8):1912–1920. https://doi.org/10.1177/1078155220907658

2. Berruti A, Generali D, Kaufmann M, Puztai L, Curigliano G et al (2011) International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, Cremona, Italy. J Natl Cancer Inst Monogr 43(1):147–151. https://doi.org/10.1093/jncimonographs/lgr037

3. Harahap Y, Ardiningsih P, Winarti AC, Purwanto DJ (2020) Analysis of the doxorubicin and doxorubicinol in the plasma of breast cancer patients for monitoring the toxicity of doxorubicin. Drug Des Devel Ther 25(14):3469–3475. https://doi.org/10.2147/DDDT.S251144

4. Ongnok B, Chattipakorn N, Chattipakon SC (2020) Doxorubicin and cisplatin induced cognitive impairment: the possible mechanisms and interventions. Exp Neurol 32(4):113–118. https://doi.org/10.1016/j.expneurol.2019.113118

5. Pugnaloni S, Vignini A, Borroni F, Sabbatinelli J, Alia S et al (2020) Modifications of taste sensitivity in cancer patients: a method for the evaluations of dysgeusia. Support Care Cancer 28(3):1173–1181

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head and neck complications of cancer therapies: taste and smell;Oral Diseases;2024-07-22

2. Photobiomodulation minimizes taste changes during hematopoietic cell transplantation: A randomized clinical trial;Journal of Biophotonics;2024-06-08

3. Non-pharmacological strategies to alleviate dysgeusia in patients undergoing chemotherapy: A systematic review;European Journal of Oncology Nursing;2024-06

4. Dysgeusia increases the risk for death and other side effects during antineoplastic systemic treatment for solid tumors: a cross-sectional study;Medicina Oral Patología Oral y Cirugia Bucal;2024

5. Preconditioning with Photobiomodulation as an Effective Method in Preventing Chemotherapy-Induced Oral Mucositis: A Systematic Review;Photobiomodulation, Photomedicine, and Laser Surgery;2023-11-01